Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Boston Children's Hospital

Boston Children's Hospital in Boston, Massachusetts, United States is listed as a site for 964 registered clinical trials, 380 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 964
Ongoing 380

This page covers the site record Boston Children's Hospital in Boston, Massachusetts, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Boston Children's Hospital, also sponsors trials.

Get the Boston Children's Hospital report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 964 trials counted.

  • Phase 1 67 trials
  • Phase 1/2 53 trials
  • Phase 2 103 trials
  • Phase 2/3 14 trials
  • Phase 3 171 trials
  • Phase 4 28 trials
  • Not applicable 230 trials
  • Observational 293 trials
  • Expanded access 5 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 381 trials
  • Completed 425 trials
  • Terminated 115 trials
  • Other 43 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 84

2002: 2 trials (Observational 1, Phase 1/2 1) 2004: 3 trials (Observational 2, Not applicable 1) 2005: 2 trials (Observational 2) 2006: 2 trials (Observational 1, Phase 3 1) 2007: 1 trials (Observational 1) 2008: 5 trials (Observational 2, Phase 3 2, Phase 2 1) 2009: 2 trials (Not applicable 1, Phase 2 1) 2010: 11 trials (Observational 6, Not applicable 1, Phase 2 1, Phase 1 3) 2011: 7 trials (Observational 1, Phase 3 1, Phase 2 2, Phase 1 3) 2012: 23 trials (Observational 8, Not applicable 8, Phase 3 3, Phase 2 1, Phase 1/2 1, Phase 1 2) 2013: 46 trials (Observational 8, Not applicable 17, Phase 4 1, Phase 3 10, Phase 2 2, Phase 1/2 1, Phase 1 7) 2014: 39 trials (Observational 12, Not applicable 8, Phase 4 2, Phase 3 4, Phase 2 6, Phase 1 7) 2015: 74 trials (Observational 32, Not applicable 14, Phase 4 2, Phase 3 7, Phase 2/3 2, Phase 2 7, Phase 1/2 5, Phase 1 5) 2016: 55 trials (Observational 14, Not applicable 15, Phase 4 1, Phase 3 12, Phase 2 10, Phase 1/2 1, Phase 1 2) 2017: 74 trials (Observational 17, Not applicable 16, Phase 4 1, Phase 3 19, Phase 2 10, Phase 1/2 7, Phase 1 4) 2018: 84 trials (Observational 31, Not applicable 21, Phase 4 1, Phase 3 18, Phase 2/3 2, Phase 2 6, Phase 1/2 1, Phase 1 4) 2019: 70 trials (Observational 21, Not applicable 13, Phase 4 3, Phase 3 13, Phase 2/3 1, Phase 2 12, Phase 1/2 3, Phase 1 4) 2020: 71 trials (Observational 33, Not applicable 10, Phase 4 3, Phase 3 10, Phase 2/3 1, Phase 2 6, Phase 1/2 3, Phase 1 5) 2021: 75 trials (Observational 21, Not applicable 20, Phase 4 4, Phase 3 16, Phase 2/3 2, Phase 2 6, Phase 1/2 6) 2022: 71 trials (Observational 22, Not applicable 11, Phase 4 2, Phase 3 18, Phase 2/3 3, Phase 2 9, Phase 1/2 4, Phase 1 2) 2023: 62 trials (Observational 10, Not applicable 22, Phase 4 1, Phase 3 14, Phase 2/3 1, Phase 2 6, Phase 1/2 3, Phase 1 5) 2024: 62 trials (Observational 18, Not applicable 19, Phase 4 2, Phase 3 8, Phase 2 7, Phase 1/2 7, Phase 1 1) 2025: 66 trials (Observational 18, Not applicable 16, Phase 4 2, Phase 3 7, Phase 2/3 1, Phase 2 9, Phase 1/2 8, Phase 1 5)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 47
2025 66
2024 62
2023 62
2022 71
2021 75
2020 71
2019 70
2018 84
2017 74

Showing 10 of 24 years.

Start your 14-day trial Email me all 24 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 5 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 964 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 173 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 515 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF